Trial Profile
A phase I study to assess safety and tolerability and neutralising activity of CL184 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2008
Price :
$35
*
At a glance
- Drugs Foravirumab (Primary) ; Rabies vaccine
- Indications Rabies
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Crucell
- 20 Dec 2006 New trial record.